<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35513033</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1891</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of ophthalmology</Title>
          <ISOAbbreviation>Am J Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Scleritis in Lyme Disease.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">S0002-9394(22)00171-4</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajo.2022.04.017</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To estimate the incidence of scleritis in Lyme disease and report clinical features.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">Incidence rate estimate and case series METHODS: Data were collected from an electronic medical record on patients with scleritis resenting to the Wilmer Eye Institute between January 1, 2012 and December 31, 2020. A diagnosis of Lyme disease was made using the Infectious Diseases Society of America, American Academy of Neurology, and the American College of Rheumatology 2020 joint criteria plus a response to antibiotic therapy. After identifying all new-onset cases of scleritis in the database, the proportion of new onset-scleritis with Lyme disease was calculated. The proportion of Lyme disease cases with scleritis was estimated using the number of cases with Lyme disease from the Baltimore Metropolitan area reported to the Centers for Disease Control. After querying other major eye centers in the area for any cases of Lyme disease scleritis, none were identified, and the incidence of Lyme disease scleritis was estimated using published US Census data for the Greater Baltimore Metropolitan area.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Six cases of Lyme disease scleritis were identified in the 8-year time frame; one additional case was identified in the following year. Lyme disease scleritis accounted for 0.6% of all cases of scleritis, and 0.052% of patients with Lyme disease had scleritis. The estimated incidence of Lyme scleritis was 0.2 per 1,000,000 population per year (95% CI 0, 0.4), whereas the estimated incidence of Lyme disease in the area was 3 per 10,000 population per year (95% CI 2.9, 3.1). All scleritis cases were anterior, unilateral, without necrosis, and resolved with antibiotic use without relapse in a median of 39.5 days (29-57). Other features of Lyme disease were present in 4/7 patients, including a history of erythema migrans in 2/7.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Lyme disease is an uncommon cause of scleritis in endemic areas.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022. Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berkenstock</LastName>
            <ForeName>Meghan K</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>From the Wilmer Eye Institute, the Department of Ophthalmology, the Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: mberken2@jhmi.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Long</LastName>
            <ForeName>Kayla</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>the University of North Texas Health Science Center Texas College of Osteopathic Medicine, Fort Worth, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miller</LastName>
            <ForeName>John B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>the Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burkholder</LastName>
            <ForeName>Bryn B</ForeName>
            <Initials>BB</Initials>
            <AffiliationInfo>
              <Affiliation>From the Wilmer Eye Institute, the Department of Ophthalmology, the Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aucott</LastName>
            <ForeName>John N</ForeName>
            <Initials>JN</Initials>
            <AffiliationInfo>
              <Affiliation>the Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, MD, USA; the Johns Hopkins Lyme Disease Clinical Research Center, Lutherville, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jabs</LastName>
            <ForeName>Douglas A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>From the Wilmer Eye Institute, the Department of Ophthalmology, the Johns Hopkins University School of Medicine, Baltimore, MD, USA; the Center for Clinical Trials and Evidence Synthesis, the Department of Epidemiology, the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Ophthalmol</MedlineTA>
        <NlmUniqueID>0370500</NlmUniqueID>
        <ISSNLinking>0002-9394</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>5</Day>
          <Hour>21</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35513033</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajo.2022.04.017</ArticleId>
        <ArticleId IdType="pii">S0002-9394(22)00171-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
